Virginia Commonwealth University: Clinical Trials

772 trials sponsored by Virginia Commonwealth University, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

482 completed, 90 terminated, 85 recruiting, 57 withdrawn. 392 Not applicable, 114 Phase 2, 85 Phase 1, 35 Phase 3, 35 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable392Completed 264, Recruiting 40, Terminated 38, Withdrawn 22, Unknown 9, Not yet recruiting 8, Active not recruiting 7, Enrolling by invitation 2, Suspended 2
Phase 2114Completed 66, Recruiting 14, Terminated 14, Withdrawn 11, Active not recruiting 4, Not yet recruiting 3, Suspended 2
Phase 185Completed 51, Terminated 11, Withdrawn 10, Recruiting 8, Active not recruiting 3, Suspended 1, Unknown 1
Phase 335Completed 19, Terminated 8, Withdrawn 6, Recruiting 1, Unknown 1
Phase 435Completed 13, Terminated 9, Recruiting 6, Withdrawn 6, Unknown 1
Early Phase 114Completed 9, Terminated 2, Not yet recruiting 1, Recruiting 1, Withdrawn 1

Follow this sponsor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Impact of Improved Vagal Function on Periaqueductal Gray Connectivity
breathing exercise training - Postural Tachycardia Syndrome
Not applicableNot yet recruitingVirginia Commonwealth University122028-01-012026-09-16
Using Apollo Neuro in Autistic Children With Self-Injurious Behavior
Apollo Neuro device - Self-Injurious Behavior, Autism Spectrum Disorder
Not applicableNot yet recruitingVirginia Commonwealth University182026-12-012026-08-17
EMBRACE (EMPA in BReast Cancer for Activity and Cardiac ProtEction)
Empagliflozin - Breast Cancer, Supportive Care in Cancer
Phase 2Not yet recruitingVirginia Commonwealth University102026-12-012026-10-20
TENS of Auricular Vagal Nerve for Radiation Necrosis
Transcutaneous auricular vagal nerve stimulation (taVNS), Sham - Radiation Necrosis, Cerebral Edema
Not applicableNot yet recruitingVirginia Commonwealth University402026-11-302026-09-04
Bedside Cranial Ultrasound for Risk-Stratified Imaging in Pediatric Acute Brain Injury
Acute Brain Injury, Traumatic Brain Injury
Not yet recruitingVirginia Commonwealth University2202026-11-302026-08-19
Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening
Changes in CRC screening awareness and intentions - Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening
Not applicableNot yet recruitingVirginia Commonwealth University302026-11-302026-10-21
Enhancing an Existing Prevention Strategy to Reduce Intentional Firearm Injuries Among High-risk Youth (Phase 1)
Establish an advisory board of high-risk youth, Feedback and advice sessions, Youth advisory board training - Prevention
Not applicableNot yet recruitingVirginia Commonwealth University452026-10-302026-09-03
FIQS Dissemination and Implementation
Text-Only Enrollment Strategy, Text Plus In-Person Enrollment Strategy, Anonymous Safety Reporting with Impact Website - Inpatient Experience Survey Administration, Inpatient Experience Survey Response
Not applicableNot yet recruitingUniversity of California, San Francisco218002026-10-192026-10-13
Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension
DM1, Myotonic Dystrophy
RecruitingVirginia Commonwealth University10002026-10-152026-10-16
Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma
Arm 1 cemiplimab, Arm 2 cemiplimab and fianlimab - Hepatocellular Carcinoma
Phase 1WithdrawnVirginia Commonwealth University2026-10-012026-09-14
Open-label Feasibility Trial of HD-tDCS During Cognitive Behavioral Therapy for Cocaine Use Disorder
High Definition Transcranial Direct Current Stimulation - Cocaine Use Disorder
Not applicableRecruitingVirginia Commonwealth University362026-10-012026-09-28
Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN
Decitabine-cedazuridine plus venetoclax (DEC-C+VEN), Azacitidine plus venetoclax (AZA+VEN) - Relapsed / Refractory AML, High Risk Myelodysplastic Syndrome
Phase 2RecruitingVirginia Commonwealth University402026-09-162026-09-21
Colon Health Champion Program
Intervention Arm: Colon Health Champions (CHC) Program - Colorectal Cancer, CRC
Not applicableNot yet recruitingVirginia Commonwealth University292026-09-102026-09-01
Southeastern ATTR Amyloidosis Consortium: SEATTRAC Family Registry
Registry - Amyloidosis, Hereditary
Not yet recruitingVirginia Commonwealth University10002026-09-012026-08-12
Transcranial Doppler Evaluation After Endovascular Thrombectomy for Acute Ischemic Stroke (PRECISE-TCD)
Transcranial Doppler (TCD) examination - Anterior Cerebral Artery Syndrome, Anterior Cerebral Artery Stroke
Not yet recruitingVirginia Commonwealth University1002026-09-012026-09-14
Quit and Screen Project
Quit and Screen Project training, G02 (Global Knowledge Center for Lung Cancer) Lung Cancer Screening training - Knowledge, Attitudes
Not applicableNot yet recruitingUniversity of Arkansas3002026-09-012026-04-13
Single FrAction Interstitial BreaSt BracHytherApy
Partial Breast Irradiation - Breast Cancer
Phase 2Not yet recruitingVirginia Commonwealth University1342026-09-012026-06-18
Sacituzumab Tirumotecan in Pts w/ NEPC After Progression on Prior Chemotherapy
Sacituzumab Tirumotecan - Prostate Cancer, Neuroendocrine Prostate Cancer (NEPC)
Phase 2Not yet recruitingVirginia Commonwealth University202026-08-312026-08-24
Biomarker-Guided Mycophenolate Mofetil Elimination in Low-Risk Older Adult Kidney Transplant Recipients
Tacrolimus (Kidney transplant maintenance immunosuppression), Mycophenoate Mofetil, Prednisone (SOC arm) - Kidney Transplant Recipient
Early Phase 1Not yet recruitingVirginia Commonwealth University202026-08-312026-09-08
Safety and Tolerability Study of VVZ-2471 in Healthy Volunteers
Placebo pills for 14-day intervention, VVZ-2471 for 14-day intervention - Healthy Controls
Phase 1RecruitingVirginia Commonwealth University602026-08-282026-09-01

Showing 20 of 772. Sign in to see all of them.

Conditions studied

Obesity (31)  ·  Breast Neoplasms (28)  ·  Brain Injuries, Traumatic (20)  ·  Heart Failure (20)  ·  Substance-Related Disorders (17)  ·  Brain Neoplasms (15)  ·  Fibrosis (15)  ·  Leukemia (15)  ·  Prostatic Neoplasms (15)  ·  Cardiovascular Diseases (14)  ·  Vaping (14)  ·  Motor Activity (13)  ·  Pediatric Obesity (13)  ·  Lung Neoplasms (12)  ·  Neoplasms (12)

Interventions

Interleukin 1 Receptor Antagonist Protein (16)  ·  Exercise (10)  ·  Radiotherapy (10)  ·  Methods (9)  ·  Ascorbic Acid (8)  ·  Therapeutics (8)  ·  Sodium Chloride (6)  ·  Cytarabine (5)  ·  Nicotine (5)  ·  Radiation (5)  ·  Restraint, Physical (5)  ·  Sorafenib (5)  ·  Standard of Care (5)  ·  Azacitidine (4)  ·  Behavior Therapy (4)

Countries

United States (711)  ·  Canada (10)  ·  Israel (6)  ·  Italy (6)  ·  United Kingdom (5)  ·  Bangladesh (4)  ·  Brazil (2)  ·  Germany (2)  ·  New Zealand (2)  ·  Australia (1)  ·  Belgium (1)  ·  Chile (1)  ·  Colombia (1)  ·  Denmark (1)  ·  India (1)

Top investigators

Antonio Abbate, MD, PhD (12)  ·  Alison Breland, PhD (10)  ·  Frederick G Moeller, MD (8)  ·  Nicholas Johnson, MD (6)  ·  Ryan Garten, PhD (6)  ·  Steven Grant, MD (6)  ·  Andrew Poklepovic, MD (5)  ·  Ashlee Loughan, PhD (5)  ·  Benjamin Van Tassell, PharmD (5)  ·  Bryant Tran, MD (5)  ·  Jeffrey S Kreutzer, PhD (5)  ·  Jessica G LaRose, PhD (5)  ·  Melanie K Bean, PhD (5)  ·  Nicholas Thomson (5)  ·  Andrew S. Poklepovic, MD (4)

Results publications

PMID 39531530, PMID 22541178, PMID 24212451, PMID 25482680, PMID 27154907, PMID 38016623, PMID 38404649, PMID 10559801, PMID 11460821, PMID 1163358, PMID 11981209, PMID 12063573, PMID 12075174, PMID 12559191, PMID 12796570, PMID 14691697, PMID 14736587, PMID 15082974, PMID 1519574, PMID 15273547, PMID 15481300, PMID 15756392, PMID 15920681, PMID 16018857, PMID 16353506, PMID 16633006, PMID 16785215, PMID 16787132, PMID 16818482, PMID 16925280, PMID 16925335, PMID 16925336, PMID 17020988, PMID 17116551, PMID 1733136, PMID 17386394, PMID 17562118, PMID 17567540, PMID 17903772, PMID 17905334, PMID 17921033, PMID 18065289, PMID 18195316, PMID 18471729, PMID 18492267, PMID 18512045, PMID 18929981, PMID 18929990, PMID 18996764, PMID 18997679

NIH funding

P30CA016059 (25), U54DA036105 (10), U54DA038999 (4), P30NR011403 (3), P50DA009262 (3), U54HD034449 (3), K23AA000222 (2), P20DA024157 (2), P50MD017319 (2), R01DA026091 (2), R01DK132373 (2), R01HD035629 (2), R21AA026681 (2), U01DK061713 (2), U01DK061718 (2)